Investor Relations

Current Price (HZD) 198.00p

You are here: Home / Investor Relations

Horizon Discovery Group plc

Investor Relations

Horizon Discovery Group plc is an international revenue-generating life science company supplying research tools, contract research services and novel research programs to organizations engaged in genomics research and the development of personalized medicines. The Group, has a signficant physical presence in Cambridge (UK), Cambridge, Massachussets (USA), St Louis, Missouri (USA), Boyertown, Pennsylvania (USA), and Vienna, Austria comprising 90,000+ sq. ft. of office and laboratory space housing >230 employees. From this base it has developed a diverse and international customer base approaching 1,000 organizations located in 50 countries, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers. The Company supplies its products and services into multiple horizontal markets, estimated in excess of £29 billion by 2015, including the translational genomics research market; the cell based assays market; the molecular diagnostics market; and the biopharmaceutical production market.

Horizon Discovery Group plc. is incorporated in England and its main country of operation is England

Details of the corporate governance code that the AIM company has decided to apply, and how the company complies with that code, are described in the AIM admission document

Applicability of the Takeover Code

The Takeover Code applies to the Company. Under the Takeover Code, if an acquisition of interests in shares were to increase the aggregate holding of the acquirer and its concert parties to interests in shares carrying 30 per cent. or more of the voting rights in the Company, the acquirer and, depending on circumstances, its concert parties would be required (except with the consent of the Panel on Takeovers and Mergers) to make a cash offer for the outstanding shares in the Company at a price not less than the highest price paid for interests in shares by the acquirer or its concert parties during the previous 12 months. This requirement would also be triggered by any acquisition of interests in shares by a person holding (together with its concert parties) shares carrying between 30 per cent. and 50 per cent. of the voting rights in the Company if the effect of such acquisition were to increase that person’s percentage of the total voting rights in the Company.

This information is being provided for AIM Rule 26 compliance

This site was last updated 02/04/2015

Latest Investor News

Login Error

There was an error with your login - please try again.

Forgotten your password? Click here

OK ×

Recover your password

Please enter your email address and we'll send you a reset link


Thank you.

We've sent you an email to reset your password.

OK ×

Add Voucher

Sorry, Unable to add voucher

OK ×

Account Error

There was an error updating your details.

OK ×

Thank you.

Your changes have been saved.

OK ×

Thank you

Thank you for registering to the Horizon Discovery website. We hope you enjoy and benefit from our online resources, and please feel free to contact us if you have any queries or feedback through the website itself or at

Got a few seconds to tell us what you're interested in?

Tick all that apply:

Horizon’s Offerings

Application Area

Disease Area


Other Disease Area (Please specify)


Thank you.

Items have been saved to your basket.

OK ×